Canada markets open in 3 hours 54 minutes

PHG Jun 2024 25.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
1.00000.0000 (0.00%)
As of 09:30AM EDT. Market open.
Full screen
Previous Close1.0000
Open1.0000
Bid0.1500
Ask3.7000
Strike25.00
Expire Date2024-06-21
Day's Range1.0000 - 1.0000
Contract RangeN/A
Volume5
Open Interest16
  • Yahoo Finance Video

    Eli Lilly seeks to expand Zepbound use to treat sleep apnea

    Eli Lilly (LLY) is reporting success in the use of Zepbound — one of the pharmaceutical giant's landmark GLP-1 weight-loss drugs — to treat sleep apnea. Yahoo Finance Health Reporter Anjalee Khemlani joins The Morning Brief to discuss Eli Lilly's filing for approval from the US Food and Drug Administration (FDA) for this use case and how it may affect makers of CPAP (Continuous Positive Airway Pressure) sleep devices, such as Philips (PHG) and ResMed (RMD). For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

  • GlobeNewswire

    Philips completes cancellation of 4.4 million shares

    June 19, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021. Philips’ current issued share capital amounts to EUR 187,987,876.80 representing 939,939,384 common shares. More information is available here. For further information,

  • Zacks

    Philips' (PHG) Diagnosis & Treatment Segment Drives Growth

    Philips (PHG) boosts Diagnosis & Treatment on the back of Precision Diagnosis and Image-Guided Therapy businesses and an expanding partner base.